在三阴性乳腺癌中构建含odomain 蛋白相关预后模型
Wei Chen1, Yushuai Yu2, Chenxi Wang3
1Department of Breast Surgery, Fujian Provincial Hospital, Shengli Clinical Medical College of Fuiian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, China.
Cancer cell international
|January 18, 2025
概括
这项研究确定了与含有基因的蛋白质相关基因 (BRDRGs) 相关的关键基因,以开发三阴性乳腺癌 (TNBC) 的预后模型. 该模型有助于理解TNBC的进展和患者的结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 含基蛋白的蛋白质 (BRD) 在恶性瘤的发展中至关重要.
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
研究的目的:
- 在TNBC中识别与BRD相关基因 (BRDRGs) 相关的预后基因.
- 开发和验证TNBC患者的新型预后模型.
主要方法:
- 使用TCGA-TNBC和GEO数据集进行分析.
- 使用ssGSEA计算了BRDRG得分,并确定了差异表达基因 (DEG).
- 使用单变Cox和LASSO回归分析构建了一个预后模型.
主要成果:
- 确定了120个差异表达的BRDRG (DE-BRDRG).
- 开发了一个六基因预后模型 (KRT6A,PGF,ABCA1,EDNRB,CTSD,GJA4).
- 高风险组显示免疫细胞丰度增加;TP53具有高突变频率.
结论:
- 为与BRDRGs相关的TNBC开发了一种经过验证的预后模型.
- 该模型为BRD-TNBC关系提供了新的见解.
- 预后基因KRT6A,ABCA1,EDNRB和CTSD显示了假名时间的逐渐减少.
相关概念视频
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


